Latest Reported Offering
$10,000
Target Amount
$1,235,000
Maximum Amount
2024-07-29
Deadline
Security Details
Type: Other
Price per share: $0.00
Price set by: N/A
Shares offered: 10,000+
Offering Costs
Cash commission: —
7 - 13 percent
Equity compensation: —
Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.
Filing history
Form C family — 6 filingsThe reported figures behind RS BioTherapeutics, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2021-02-08
Website
Latest Metrics
Employees2
Total Assets$13,808
Cash on Hand$9,303
Revenues$1,779
Net Income-$204,031
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.